This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Instytut Farmakologii Polskiej Akademii Nauk. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Inventor Jakub Staron: Pioneering Innovations in Serotonin Receptor Activation
Introduction
Jakub Staron, based in Cracow, Poland, is an accomplished inventor known for his significant contributions to pharmacology. With one patent to his name, he has developed innovative compounds aimed at enhancing therapeutic approaches to central nervous system disorders through selective serotonin receptor activation.
Latest Patents
Staron's notable patent is titled "Imidazolyl-substituted indole derivatives binding 5-HT7 serotonin receptor and pharmaceutical compositions thereof." This invention introduces a new class of substituted indole derivatives that exhibit the ability to activate the 5-HT serotonin receptor. These compounds demonstrate high affinity and selectivity for the 5-HT receptor while also possessing favorable physicochemical properties. Notably, they are recognized as the first described low-basicity 5-HT receptor agonists. The implications of this invention extend to the treatment or prevention of 5-HT receptor-related disorders, particularly concerning the central nervous system. Additionally, the patent includes isotopically labelled compounds for in vivo diagnostics or imaging of the 5-HT serotonin receptor.
Career Highlights
Jakub Staron is currently affiliated with the Institute of Pharmacology of the Polish Academy of Sciences, where he is actively involved in research and development within the field of pharmacology. His focus on serotonin receptor mechanisms is pivotal in advancing our understanding and treatment of various neurological conditions.
Collaborations
In his research journey, Staron collaborates with notable colleagues, including Adam Hogendorf and Agata Hogendorf. Their combined expertise enhances the Innovative research outcomes, contributing to breakthroughs in the pharmaceutical sciences.
Conclusion
With his innovative work and a strong emphasis on serotonin receptor activation, Jakub Staron is making significant strides in the medical field. His patent represents a crucial advancement in understanding and addressing central nervous system disorders, showcasing the impactful role of inventors in enhancing human health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile